Stromal Reprogramming through Dual PDGFRa/b Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

  • Takahiko Akiyama
  • , Tadahito Yasuda
  • , Tomoyuki Uchihara
  • , Noriko Yasuda-Yoshihara
  • , Benjy J.Y. Tan
  • , Atsuko Yonemura
  • , Takashi Semba
  • , Juntaro Yamasaki
  • , Yoshihiro Komohara
  • , Koji Ohnishi
  • , Feng Wei
  • , Lingfeng Fu
  • , Jun Zhang
  • , Fumimasa Kitamura
  • , Kohei Yamashita
  • , Kojiro Eto
  • , Shiro Iwagami
  • , Hirotake Tsukamoto
  • , Terumasa Umemoto
  • , Mari Masuda
    • Osamu Nagano, Yorifumi Satou, Hideyuki Saya, Patrick Tan, Hideo Baba, Takatsugu Ishimoto

Research output: Contribution to journal › Article › peer-review

73 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Stromal Reprogramming through Dual PDGFRa/b Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry